India bears a significant burden of Lymphatic Filariasis (LF) as one of the
countries with the highest prevalence globally. The prevalence of LF in India is fueled
by a complex interplay of socio-economic factors, inadequate healthcare infrastructure,
and environmental conditions conducive to mosquito breeding. The disease primarily
affects the lymphatic system, leading to severe and disfiguring manifestations such as
lymphedema, elephantiasis, and hydrocele. These debilitating conditions not only
impact the physical health of individuals but also contribute to social stigmatization
and economic hardships. India has undertaken commendable efforts to combat LF
through mass drug administration (MDA) campaigns, which involve the distribution of
antifilarial drugs to entire at-risk populations. However, challenges such as incomplete
coverage, drug compliance, and the persistence of transmission in certain areas hinder
the success of these initiatives.
Keywords: Albendazole, Antifilarial drug, Chyluria, Diethylcarbamazine, Elephantiasis, Endemic region, Hhydrocele, Ivermectin, Indoor residual spray, Iintegrated vector management, Knott’s concentration technique, Lymphedema, Lymphatic filariasis, Long lasting insecticidal net, Mass drug administration, Mazzotti reaction, Microfilariae, Neglected tropical disease, Peripheral blood smear, Vector control strategies.
